Syndax Pharmaceuticals Inc

Bank of New York Mellon Corp SNDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

1,094,151

Value ($000)

22,988

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	22,988	0.0%	1,094,151	12/31/2025
2025 Q3	11/3/2025	16,190	0.0%	1,052,335	9/30/2025
2025 Q2	8/5/2025	2,220	0.0%	237,101	6/30/2025
2025 Q1	4/29/2025	2,823	0.0%	229,758	3/31/2025
2024 Q4	2/4/2025	2,965	0.0%	224,261	12/31/2024
2024 Q3	11/12/2024	4,264	0.0%	221,502	9/30/2024
2024 Q2	7/25/2024	5,991	0.0%	291,826	6/30/2024
2024 Q1	4/25/2024	5,840	0.0%	245,363	3/31/2024
2023 Q4	1/29/2024	4,989	0.0%	230,858	12/31/2023
2023 Q3	10/24/2023	3,303	0.0%	227,504	9/30/2023
2023 Q2	8/3/2023	4,918	0.0%	234,980	6/30/2023
2023 Q1	5/9/2023	4,472	0.0%	211,723	3/31/2023
2022 Q4	2/14/2023	4,899	0.0%	192,483	12/31/2022
2022 Q3	11/14/2022	4,547	0.0%	189,194	9/30/2022
2022 Q2	8/15/2022	3,217	0.0%	167,187	6/30/2022
2022 Q1	5/11/2022	3,066	0.0%	176,391	3/31/2022
2021 Q4	2/11/2022	3,647	0.0%	166,572	12/31/2021
2021 Q3	11/18/2021	3,218	0.0%	168,350	9/30/2021
2021 Q2	8/11/2021	2,524	0.0%	146,945	6/30/2021
2021 Q1	5/13/2021	2,918	0.0%	130,515	3/31/2021
2020 Q4	2/9/2021	2,903	0.0%	130,515	12/31/2020
2020 Q3	11/12/2020	1,528	0.0%	103,559	9/30/2020
2020 Q2	8/12/2020	1,534	0.0%	103,541	6/30/2020
2020 Q1	5/6/2020	906	0.0%	82,622	3/31/2020
2019 Q4	2/14/2020	658	0.0%	74,987	12/31/2019